Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation.

Blood
Pierre FeugierJean-Marie Andrieu

Abstract

Lymphocyte-predominant Hodgkin lymphoma (LPHL), according to the Revised European-American Lymphoma classification, was considered on a retrospective basis as a specific clinical entity with a large majority of patients at clinical stage (CS) IA or IIA. Of the 500 patients with CS IA/IIA Hodgkin lymphoma (HL) prospectively treated between 1981 and 1996 by one or 3 courses of anthracycline-based chemotherapies combined with high-dose extended irradiation, disease in 42 patients was reclassified as LPHL. These 42 patients, none of whom had mediastinal involvement (MI), were compared with the 458 patients with classical HL (cHL), 144 without MI and 314 with MI. Surprisingly, the male-female ratio, age, first site involved, hemoglobin level, lymphocyte count, and sedimentation rate of patients with LPHL and cHL without MI were identical and significantly different from those of patients with cHL with MI. Moreover, 15-year HL mortality rates were similarly low in patients with LPHL (2.4%) and cHL without MI (0.7%). Overall survival rates were also similar (86% and 82%) and as high as 100% and 95% in patients treated before the age of 40 years. This study demonstrated that LPHL and cHL without MI shared the same presenting characteri...Continue Reading

Citations

Mar 1, 2006·Current Hematologic Malignancy Reports·Lucia NogovàUNKNOWN German Hodgkin Study Group
Jul 1, 2008·Current Hematologic Malignancy Reports·Michael FuchsUNKNOWN German Hodgkin Study Group
May 15, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Laura GalánMariano Provencio
Mar 25, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C JacksonA Wotherspoon
Dec 21, 2013·Blood·Joseph M Connors
Mar 25, 2006·Future Oncology·Stefan Fruehauf, Timon Seeger
Jun 27, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Jean François GrellierPauline Brice
Nov 6, 2015·British Journal of Haematology·Pamela McKayUNKNOWN British Committee for Standards in Haematology
Jul 13, 2005·European Journal of Haematology. Supplementum·Lucia NogováAndreas Engert
Feb 13, 2013·British Journal of Haematology·Katharine H Xing, Kerry J Savage
Jun 27, 2007·Seminars in Radiation Oncology·Henry K Tsai, Peter M Mauch
May 28, 2013·Case Reports in Hematology·Géraldine SalmeronDavid Sibon
Mar 22, 2014·Clinical Lymphoma, Myeloma & Leukemia·Anupama GoelMichael L Grossbard
Apr 13, 2015·International Journal of Radiation Oncology, Biology, Physics·Martin T KingRichard T Hoppe
Nov 12, 2013·Blood·Ranjana H Advani, Richard T Hoppe
Aug 9, 2016·Seminars in Hematology·Kerry J SavageMichelle Fanale
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George P Canellos
Nov 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald C ChenPeter M Mauch
Jul 17, 2009·The Oncologist·Alfred Ian Lee, Ann S LaCasce
Nov 30, 2018·British Journal of Haematology·Michael A SpinnerRanjana H Advani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.